Table 1 Experimental Design: A Study layout depicting the treatment groups, dosing concentrations, timepoints, and endpoints. All the compounds were continuously dosed in both channels at 400 µL/h for seven days.

From: Hepatotoxicity evaluation of cannabidiol, cannabinol, cannabichromene and cannabigerol using a human quad culture liver chip